Mission Therapeutics’ Post

How does the only Global Integrated Analytical Biorepository facilitate translational research? Translational research is an essential bridge between fundamental research findings and clinical application, requiring meticulous management of complex, long-term projects with the highest research standards. Read our latest white paper to learn more about how Sampled is here to support throughout the drug development pipeline: https://lnkd.in/e7V5ifnF #TranslationalResearch #GIAB #TeamSampled

Dr Adriana Kiędzierska - Mencfeld, Chief Integration Officer, will share her extensive experience in #biomanufacturing during upcoming #CEBioForum2024 conference.  Adriana will take part in the discussion "How to handle biomanufacturing?" #BiotechConference  #Biomanufacturing #CEBioForum2024 #Panelist #Innovation #PolpharmaBiologics

An article highlighting Providence Research’s contributions to British Columbia’s growing ecosystem of biotechnology research is featured in the latest edition of BIOTECanada's Insights magazine, which is dedicated to showcasing the best of Canadian biotechnology. The spring issue of Insights showcases exclusive interviews with industry leaders, federal government perspectives, and ground-breaking research highlighting the dynamic landscape and future potential of Canada’s biotech sector. The article from Dr. Darryl Knight, President, Providence Research, covers the new Phase 1 Clinical Trials Unit at Mount Saint Joseph Hospital, and the consolidated Phase 1-3 Clinical Trials Unit that will be included at the Clinical Support and Research Centre at the new St. Paul’s Hospital. These state-of-the-art research facilities will serve a growing demand for non-cancer Phase 1 clinical trials in B.C., and foster collaboration between researchers, clinicians and industry experts to advance medical discovery. Read it here: https://lnkd.in/gr9KEd_C #research #healthcare #healthresearch #clinicaltrials #innovation #biotech #biotechnology

👩🔬👨🔬💰Last call - until September 22nd you can still submit an application for the Merck Group 2024 Research Grants! Merck's 2024 Research Grants aim to foster innovation in cutting-edge scientific fields that the company focuses on. Grants are offered in several categories: 1. Molecular Glue Degraders: Up to €100,000/year for three years to support new approaches in this therapeutic area. 2. Digital Twin Development for Augmented Reality: A one-time grant of €120,000 for 1 year to explore digital transformation in research. 3. AI-driven Drug Discovery: Access to AIDDISON software licenses for selected projects. 📝 Applicants must first submit a non-confidential proposal. Selected candidates will be invited to a deep-dive workshop. To participate you need to be affiliated with a university, a research center or a company. For more details, visit Merck’s website. #merck #researchgrants #grants #drugdiscovery #aiddison #AIdrugdiscovery #digitaltwin #ARdigitaltwin

#E_Conference #Advanced_Drug_Discovery_and_Development November 11, 2024 November 13, 2024 Organized by Shanghai Institute for Advanced Immunochemical Studies (#SIAIS), iHuman Institute, School of Life Science and Technology (#SLST), School of Biomedical Engineering (#BME), Shanghai Clinical Research and Trial Center, National Center for Protein Science Shanghai (#NCPSS), #Nature_Communications The aim of this conference is to be a premier international forum that provides direction on the latest developments through keynote presentations by high-level experts in the field of #drug_discovery and #drug_development, and to provide a stage for young scientists aspiring to professorships in the near future to exchange excellent research. The focus of the conference is on #cutting_edge_research in the field of drug discovery and development, both in terms of new approaches and technologies as well as new drugs in drug discovery and development. For technologies, we will particularly focus on #artificial_intelligence, degradation technologies for design such as #PROTACs and #molecular_glues, #gene_editing, #DNA_encoded compound libraries, nucleic acid drugs, etc.; for drugs, we will emphasize the discovery of first-in-class targets and new molecules. The conference will provide networking opportunities with the peers to help establish connections for early career scientists to meet a diverse mix of researchers. Session details: 1. Drug target identification and validation 2. Advanced Lead Discovery and Generation Technologies 3. Emerging New Drug Modalities For Free registration Click on the link given below. https://lnkd.in/gfsdVqha

The same molecular complexity that makes biotherapeutics effective treatments also poses a significant challenge at the manufacturing level 💡 Sean Keng Rui Chia, Senior Scientist at the A*STAR Bioprocessing Technology Institute (BTI), has been working alongside fellow researchers to overcome this hurdle. “At BTI, we’re studying the developability properties—such as the specificity and aggregation propensity—of next-generation antibody therapeutics like multispecific antibodies,” he shared with A*STAR Research. “As part of this work, we design new assays and computational models to assess these therapeutic molecules and optimise their properties.” 🌟 In 2022, Chia was awarded the prestigious Singapore Biodesign Innovation Fellowship, which opened the door for him to explore the world of health and medtech innovation with the support of experienced mentors. Head to the comments section for the link to the full story 👇 --- #scicomm #science #technology #STEM #research #innovation #ASTAR #biotherapeutics #biologics #healthcare #HHP #industry #Singapore

Join our scientific team Maria Pia Catalani, Jean-Francois Rolland and Alessandro Cinti at BOOTH 410 to discuss the latest innovations in drug discovery!    But that's not all! Don’t miss Alessandro’s 30-minute talk on Targeted Protein Degradation (TPD): A New Frontier in Drug Discovery:   🧬 Abstract: Targeted Protein Degradation (TPD) offers a novel approach to modulate the intracellular levels of disease-causing proteins. Here, we will delve into the practical aspects of TPD, focusing on the development and implementation of cell-based assays aimed at monitoring target protein levels, and will discuss how complementary cell-based and cell-free assays support the discrimination of unspecifically-interfering compounds and detailed characterization and further development of hit compounds.   📅 Date: October 2, 2024 📍 Location: Boston, MA, USA   #DiscoveryOnTarget2024 #DoT #TargetedProteinDegradation #TPD #Innovation #DrugDiscovery 

Thrilled to share this insightful article on the latest advances, applications, and combined approaches in High-Throughput Screening (HTS). Check out the comprehensive exploration of cutting-edge technologies shaping the future of scientific discovery: 🔍 Key Takeaways: ·     Unveiling novel applications of HTS in various fields. ·     Exploring advanced technologies driving high-throughput processes.  · Insights into the power of combined approaches for enhanced results. Kudos to the team at Technology Networks for this informative piece! Dive into the details here: https://lnkd.in/dMFrwGPe  #HighThroughputScreening #ScientificInnovation #Biopharma #biotechnology  

I am incredibly proud to announce that we have been awarded a £1.6M project from Innovate UK’s Biomedical Catalyst 2023 Round 2: Industry-led R&D 🙌 This application took a tremendous amount of effort, including working well into the early hours of many mornings to perfect the initial submission and cancelling leave over Christmas to prepare for the interview stage. Innovate UK grants (rightly!) require significant work; the application is scrutinised by five experienced assessors from various areas across Life Sciences. The next-stage interview is then attended by up to ten other people, with our panel including professionals from the NHS, academia, and CDMOs, among others. With a pot of £17.8M, and average project cost at £415,191, only 30 of the 358 applications could be funded 💰 . It is therefore truly gratifying to have so many experts agree that the cause we are developing solutions for is important and worthy of this substantial investment ✊ We do not take this funding lightly and will work tirelessly to ensure the success of our exciting project. Time to get cracking! https://lnkd.in/ev58aTt8 #biomedicalcatalyst #healthcare #infantmicrobiome #microbiome #grantfunding #grants #investment #innovateuk #biotech

Word-up my fellow space medicine nerds! Thank you to everyone who made the IAC2024 conference a success! For those interested, mark your calendars for a free webinar on October 29th discussing "The Future of Medicine and Biotechnology In Space." Learn about the exciting opportunities for industrial pharmaceutical and biomanufacturing in microgravity. Pings to: Ivy Mayor Johannes N. Svensøy Michail Magkos and Shawna Pandya, MD #SpaceMedicine #Medicine #Microgravity